Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
When would you recommend postmastectomy radiation to a male, status post mastectomy with 1/1 sentinel nodes with ITCs?
Answer from: Radiation Oncologist at Community Practice
Upfront ITC is not an indication for PMRT unless indicated for T factor. ITC after chemo, would treat like node-positive with PMRT.
Sign In
or
Register
to read more
Answer from: Radiation Oncologist at Community Practice
If T1-T2 with ITCs, I would not recommend PMRT. If T3 with ITCs, I would discuss the pros/cons and favor if ER-. If T4, I would recommend.
Comments
Radiation Oncologist at Radiation Oncology Associates P.C.
Would the presence of ITCs in multiple sentinel no...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
It would not. As Dr. @Sushil Beriwal noted, i...
Radiation Oncologist at Radiation Oncology Associates P.C.
Thank you.
3872
3877
3887
Sign In
or
Register
to read more
Answer from: Radiation Oncologist at Community Practice
For those seeking reference data on the above question, here are a couple: Karam et al., PMID 24035330 Mittendorf et al., PMID 25488970
Sign In
or
Register
to read more
9093
9088
10713
Related Questions
Is it reasonable to extrapolate the findings of RT Charm and Alliance to intact breast patients and offer hypofractionated RNI to all patients who are eligible for RNI?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
What is the maximum dose that you would give to residual unresectable gross disease in the axilla in the setting of recurrent breast cancer s/p ALND?
In what circumstances would you offer axillary re-irradiation after salvage axillary dissection?
How do you approach boost to the lumpectomy cavity AND 4 lymph nodes with extra-nodal extension when treating breast cancer with hypofractionation?
Given the 10-year outcomes of UK FAST-Forward presented at ESTRO, how have you expanded the use of ultra-hypofractionation in your practice?
Do you recommend high ozonated oil for radiation dermatitis?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
Would you consider whole breast re-irradiation in a patient with a second/recurrent breast cancer and prior history of breast radiation therapy many years ago, if the tumor characteristics are not amenable to partial breast re-irradiation?